Project Details
Projekt Print View

Epigenetic regulation of hepatic gene expression in the pathogenesis of insulin resistance

Subject Area Endocrinology, Diabetology, Metabolism
Gastroenterology
Term from 2015 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 279373746
 
Final Report Year 2023

Final Report Abstract

We identified altered DNA methylation in visceral adipose tissue of humans with impaired glucose tolerance and associated dysregulation of gene expression and metabolic parameters. Moreover, we identified microRNA 182-5p as important regulator of hepatic insulin sensitivity and contributor to the development of fatty liver diseases. Therefore, future studies should focus on antagonizing hepatic microRNA 182-5p in order to improve insulin resistance and fatty liver. Overall, we demonstrated the epigenetic alterations in metabolically active tissue of humans with type 2 diabetes exist and that these alterations likely contribute to the development and manifestation of metabolic diseases. In mice, epigenetic dysregulation is dynamically induced by high-fat feeding, causal for the development of insulin resistance and can be reversed by weight loss.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung